An	O
AP1	B-DNA
binding	I-DNA
site	I-DNA
upstream	O
of	O
the	O
kappa	B-DNA
immunoglobulin	I-DNA
intron	I-DNA
enhancer	I-DNA
binds	O
inducible	B-protein
factors	I-protein
and	O
contributes	O
to	O
expression	O
.	O

Expression	O
of	O
the	O
kappa	O
immunoglobulin	O
light	O
chain	O
gene	O
requires	O
developmental-	O
and	O
tissue-specific	O
regulation	O
by	O
trans-acting	B-protein
factors	I-protein
which	O
interact	O
with	O
two	O
distinct	O
enhancer	B-DNA
elements	I-DNA
.	O

A	O
new	O
protein-DNA	O
interaction	O
has	O
been	O
identified	O
upstream	O
of	O
the	O
intron	B-DNA
enhancer	I-DNA
,	O
within	O
the	O
matrix-associated	B-DNA
region	I-DNA
of	O
the	O
J-C	B-DNA
intron	I-DNA
.	O

The	O
binding	O
activity	O
is	O
greatly	O
inducible	O
in	O
pre-B	B-cell_type
cells	I-cell_type
by	O
bacterial	O
lipopolysaccharide	O
and	O
interleukin-1	B-protein
but	O
specific	O
complexes	O
are	O
found	O
at	O
all	O
stages	O
of	O
B	O
cell	O
development	O
tested	O
.	O

The	O
footprinted	B-DNA
binding	I-DNA
site	I-DNA
is	O
homologous	O
to	O
the	O
consensus	B-DNA
AP1	I-DNA
motif	I-DNA
.	O

The	O
protein	O
components	O
of	O
this	O
complex	O
are	O
specifically	O
competed	O
by	O
an	O
AP1	B-DNA
consensus	I-DNA
motif	I-DNA
and	O
were	O
shown	O
by	O
supershift	O
to	O
include	O
c-Jun	B-protein
and	O
c-Fos	B-protein
,	O
suggesting	O
that	O
this	O
binding	B-DNA
site	I-DNA
is	O
an	O
AP1	B-DNA
motif	I-DNA
and	O
that	O
the	O
Jun	B-protein
and	I-protein
Fos	I-protein
families	I-protein
of	O
transcription	B-protein
factors	I-protein
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
the	O
kappa	B-DNA
light	I-DNA
chain	I-DNA
gene	I-DNA
.	O

Mutation	O
of	O
the	O
AP1	B-DNA
motif	I-DNA
in	O
the	O
context	O
of	O
the	O
intron	B-DNA
enhancer	I-DNA
was	O
shown	O
to	O
decrease	O
enhancer-mediated	O
activation	O
of	O
the	O
promoter	O
in	O
both	O
pre-B	B-cell_type
cells	I-cell_type
induced	O
with	O
LPS	O
and	O
constitutive	O
expression	O
in	O
mature	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

©	NULL
1994	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
5425-5432	NULL
An	NULL
AP1	NULL
binding	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
kappa	NULL
immunoglobulin	NULL
intron	NULL
enhancer	NULL
binds	NULL
inducible	NULL
factors	NULL
and	NULL
contributes	NULL
to	NULL
expression	NULL
Judith	NULL
T.Schanke	NULL
,	NULL
Adriana	NULL
Marcuzzi	NULL
'	NULL
,	NULL
Raymond	NULL
P.Podzorski	NULL
?	NULL

and	NULL
Brian	NULL
Van	NULL
Ness*	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
the	NULL
Institute	NULL
of	NULL
Human	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
55455	NULL
,	NULL
'Department	NULL
of	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
Southern	NULL
Illinois	NULL
,	NULL
Springfield	NULL
,	NULL
IL	NULL
and	NULL
*Department	NULL
of	NULL
Immunology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
,	NULL
USA	NULL
Received	NULL
July	NULL
18	NULL
,	NULL
1994	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
October	NULL
21	NULL
,	NULL
1994	NULL
ABSTRACT	NULL
Expression	NULL
of	NULL
the	NULL
kappa	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
gene	NULL
requires	NULL
developmental-	NULL
and	NULL
tissue-specific	NULL
regulation	NULL
by	NULL
trans-acting	NULL
factors	NULL
which	NULL
interact	NULL
with	NULL
two	NULL
distinct	NULL
enhancer	NULL
elements	NULL
.	NULL

A	NULL
new	NULL
protein	NULL
-	NULL
DNA	NULL
interaction	NULL
has	NULL
been	NULL
identified	NULL
upstream	NULL
of	NULL
the	NULL
intron	NULL
enhancer	NULL
,	NULL
within	NULL
the	NULL
matrix-associated	NULL
region	NULL
of	NULL
the	NULL
J-C	NULL
intron	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
is	NULL
greatly	NULL
inducible	NULL
in	NULL
pre-B	NULL
cells	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
and	NULL
interleukin-1	NULL
but	NULL
specific	NULL
complexes	NULL
are	NULL
found	NULL
at	NULL
all	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
tested	NULL
.	NULL

The	NULL
footprinted	NULL
binding	NULL
site	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
consensus	NULL
AP1	NULL
motif	NULL
.	NULL

The	NULL
protein	NULL
components	NULL
of	NULL
this	NULL
complex	NULL
are	NULL
specifically	NULL
competed	NULL
by	NULL
an	NULL
AP1	NULL
consensus	NULL
motif	NULL
and	NULL
were	NULL
shown	NULL
by	NULL
supershift	NULL
to	NULL
include	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
binding	NULL
site	NULL
is	NULL
an	NULL
AP1	NULL
motif	NULL
and	NULL
that	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
kappa	NULL
light	NULL
chain	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AP1	NULL
motif	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intron	NULL
enhancer	NULL
was	NULL
shown	NULL
to	NULL
decrease	NULL
enhancer-mediated	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
both	NULL
pre-B	NULL
cells	NULL
induced	NULL
with	NULL
LPS	NULL
and	NULL
constitutive	NULL
expression	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
kappa	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
gene	NULL
intron	NULL
enhancer	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
thoroughly	NULL
characterized	NULL
mammalian	NULL
regulatory	NULL
regions	NULL
.	NULL

The	NULL
intron	NULL
enhancer	NULL
is	NULL
comprised	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cis-acting	NULL
elements	NULL
spanning	NULL
250	NULL
bases	NULL
of	NULL
the	NULL
J-C	NULL
intron	NULL
and	NULL
is	NULL
bound	NULL
by	NULL
numerous	NULL
trans-acting	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
either	NULL
ubiquitously	NULL
expressed	NULL
or	NULL
interact	NULL
with	NULL
the	NULL
enhancer	NULL
at	NULL
specific	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

A	NULL
number	NULL
of	NULL
inducible	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
the	NULL
intron	NULL
enhancer	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
,	NULL
including	NULL
NF-xB	NULL
which	NULL
is	NULL
primarily	NULL
responsible	NULL
for	NULL
intron	NULL
enhancer	NULL
activity	NULL
(	NULL
for	NULL
review	NULL
see	NULL
1	NULL
)	NULL
and	NULL
xB-FA	NULL
,	NULL
an	NULL
inducible	NULL
interaction	NULL
found	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
intron	NULL
enhancer	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
matrix-associated	NULL
region	NULL
(	NULL
MAR	NULL
)	NULL
(	NULL
3	NULL
)	NULL
.	NULL

While	NULL
this	NULL
regions	NULL
is	NULL
bound	NULL
by	NULL
protein	NULL
components	NULL
of	NULL
the	NULL
nuclear	NULL
matrix	NULL
or	NULL
scaffolding	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
proposed	NULL
that	NULL
these	NULL
MAR	NULL
proteins	NULL
may	NULL
include	NULL
transcription	NULL
factors	NULL
(	NULL
4,5	NULL
)	NULL
.	NULL

Very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
protein-DNA	NULL
interactions	NULL
upstream	NULL
of	NULL
the	NULL
kappa	NULL
intron	NULL
enhancer	NULL
that	NULL
includes	NULL
the	NULL
MAR	NULL
.	NULL

In	NULL
this	NULL
study	NULL
a	NULL
novel	NULL
site	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
was	NULL
identified	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
core	NULL
intron	NULL
enhancer	NULL
,	NULL
within	NULL
the	NULL
MAR	NULL
of	NULL
the	NULL
kappa	NULL
light	NULL
chain	NULL
gene	NULL
.	NULL

We	NULL
found	NULL
a	NULL
number	NULL
of	NULL
different	NULL
protein-DNA	NULL
complexes	NULL
are	NULL
formed	NULL
at	NULL
this	NULL
site	NULL
,	NULL
at	NULL
distinct	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

One	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
is	NULL
greatly	NULL
increased	NULL
in	NULL
a	NULL
pre-B	NULL
cell	NULL
line	NULL
when	NULL
induced	NULL
with	NULL
LPS	NULL
or	NULL
IL-1	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
of	NULL
enhancer-containing	NULL
reporter	NULL
gene	NULL
constructs	NULL
suggest	NULL
that	NULL
this	NULL
interaction	NULL
results	NULL
in	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
enhancer	NULL
activity	NULL
.	NULL

Competition	NULL
binding	NULL
studies	NULL
as	NULL
well	NULL
as	NULL
supershifts	NULL
with	NULL
antibodies	NULL
to	NULL
the	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
proteins	NULL
indicate	NULL
that	NULL
this	NULL
motif	NULL
is	NULL
an	NULL
API	NULL
site	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
xAP1	NULL
DNA	NULL
probes	NULL
and	NULL
competitors	NULL
The	NULL
complementary	NULL
oligonucleotides	NULL
used	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
are	NULL
listed	NULL
below	NULL
.	NULL

For	NULL
DNA	NULL
probes	NULL
,	NULL
single-stranded	NULL
oligonucleotides	NULL
were	NULL
end-labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
annealed	NULL
to	NULL
the	NULL
complementary	NULL
strand	NULL
,	NULL
and	NULL
purified	NULL
with	NULL
Biospin	NULL
6	NULL
columns	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
xAPI1	NULL
oligonucleotides	NULL
used	NULL
were	NULL
:	NULL
5	NULL
'	NULL
ATGCAAAAATATGACTAATAATAATTTAGCACA	NULL
3	NULL
'	NULL
and	NULL
5	NULL
TGTGCTAAATTATTATTAGTCATATTTTTGCAT	NULL
3	NULL
.	NULL

The	NULL
API	NULL
consensus	NULL
oligonucleotides	NULL
used	NULL
were	NULL
:	NULL
5	NULL
CTAGAT-CCTCTAGAACTGACTCATCGGATCTAC	NULL
3	NULL
'	NULL
and	NULL
5	NULL
GTA-GATCCGATGAGTCAGTTCTAGAGGATCTAG	NULL
3	NULL
'	NULL
.	NULL

The	NULL
non-specific	NULL
oligonucleotides	NULL
used	NULL
as	NULL
competitor	NULL
DNA	NULL
were	NULL
:	NULL
5	NULL
'	NULL
CAGAGGGGACTTTCCGGCCGGCATCTGGCAG	NULL
3	NULL
'	NULL
and	NULL
5	NULL
)	NULL
CTGCCAGATGCCGGCCGGAAAGTCCCCTCTG	NULL
3	NULL
,	NULL
which	NULL
contain	NULL
the	NULL
xB	NULL
and	NULL
xEl	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
human	NULL
xAPI	NULL
oligonucleotides	NULL
used	NULL
were	NULL
5	NULL
GCTTTCCTTGACTCAGCCGC-TGCC	NULL
3	NULL
``	NULL
and	NULL
5°	NULL
GGCAGCGGCTGAGTCAAGGAAAGC	NULL
3	NULL
'	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
sequence	NULL
320	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
.	NULL

The	NULL
*To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
5426	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
mutated	NULL
mouse	NULL
xAP1	NULL
oligonucleotides	NULL
(	NULL
designated	NULL
mxAP1	NULL
)	NULL
used	NULL
were	NULL
5	NULL
'	NULL
ATGCAAAAATACTGTTAACAATAATTTAGCAC-A	NULL
3	NULL
'	NULL
and	NULL
5°	NULL
TGTGCTAAATTATTGTTAACAGTATTTIT-TGCAT	NULL
3	NULL
'	NULL
.	NULL

Nuclear	NULL
extracts	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
footprinting	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
and	NULL
Roeder	NULL
(	NULL
6	NULL
)	NULL
with	NULL
previously	NULL
described	NULL
modifications	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
10	NULL
ug	NULL
nuclear	NULL
extract	NULL
,	NULL
0.5-1	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
20,000	NULL
cpm	NULL
(	NULL
0.2-1.0	NULL
ng	NULL
)	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
in	NULL
a	NULL
final	NULL
reaction	NULL
volume	NULL
of	NULL
20-25	NULL
ul	NULL
,	NULL
and	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Competition	NULL
binding	NULL
reactions	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
the	NULL
indicated	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
95	NULL
bp	NULL
Mboll	NULL
-Alul	NULL
restriction	NULL
fragment	NULL
was	NULL
labeled	NULL
at	NULL
one	NULL
end	NULL
and	NULL
incubated	NULL
with	NULL
LPS-induced	NULL
70Z	NULL
nuclear	NULL
extract	NULL
.	NULL

2	NULL
units/ml	NULL
DNase	NULL
I	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
90	NULL
s	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
EDTA	NULL
to	NULL
10	NULL
mM	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
for	NULL
the	NULL
mobility	NULL
shift	NULL
,	NULL
and	NULL
the	NULL
B4	NULL
complex	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
the	NULL
DNA	NULL
eluted	NULL
,	NULL
then	NULL
denatured	NULL
and	NULL
run	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
along	NULL
with	NULL
an	NULL
A/G	NULL
sequencing	NULL
ladder	NULL
of	NULL
the	NULL
same	NULL
fragment	NULL
.	NULL

After	NULL
drying	NULL
the	NULL
gel	NULL
it	NULL
was	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

Binding	NULL
reactions	NULL
for	NULL
antibody	NULL
complex	NULL
supershifts	NULL
included	NULL
the	NULL
preincubation	NULL
of	NULL
1.5	NULL
ug	NULL
rabbit	NULL
polyclonal	NULL
c-Jun	NULL
antibody	NULL
(	NULL
Ab-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
c-Fos	NULL
antibody	NULL
(	NULL
Ab-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
,	NULL
or	NULL
NF-xB	NULL
p65	NULL
antibody	NULL
(	NULL
Pharmingen	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Plasmid	NULL
constructs	NULL
A	NULL
wild-type	NULL
595	NULL
bp	NULL
kappa	NULL
enhancer	NULL
fragment	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
xAP1	NULL
oligonucleotide	NULL
(	NULL
see	NULL
above	NULL
)	NULL
and	NULL
an	NULL
oligonucleotide	NULL
of	NULL
the	NULL
sequence	NULL
downstream	NULL
of	NULL
the	NULL
enhancer	NULL
at	NULL
the	NULL
closest	NULL
AZul	NULL
site	NULL
(	NULL
5	NULL
'	NULL
TAGCCAAGCTTAACCTACTG	NULL
3	NULL
``	NULL
)	NULL
and	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
TA	NULL
cloning	NULL
vector	NULL
,	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
amplification	NULL
and	NULL
subsequent	NULL
TA	NULL
cloning	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
same	NULL
downstream	NULL
primer	NULL
and	NULL
an	NULL
upstream	NULL
primer	NULL
containing	NULL
four	NULL
base	NULL
changes	NULL
within	NULL
the	NULL
xAPI1	NULL
site	NULL
(	NULL
mxAP1	NULL
)	NULL
(	NULL
sequences	NULL
given	NULL
above	NULL
)	NULL
.	NULL

The	NULL
Sacl-Xhol	NULL
fragments	NULL
containing	NULL
these	NULL
enhancers	NULL
were	NULL
then	NULL
isolated	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
compatible	NULL
site	NULL
of	NULL
KpLUC	NULL
(	NULL
28	NULL
)	NULL
to	NULL
form	NULL
Kp	NULL
595	NULL
and	NULL
Kp	NULL
(	NULL
mxAP1	NULL
)	NULL
595	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
prepared	NULL
independently	NULL
twice	NULL
and	NULL
two	NULL
independent	NULL
isolates	NULL
of	NULL
each	NULL
construct	NULL
were	NULL
typically	NULL
assayed	NULL
.	NULL

Mutations	NULL
and	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
enhancer	NULL
were	NULL
confirmed	NULL
by	NULL
sequencing	NULL
all	NULL
constructs	NULL
.	NULL

Transient	NULL
transfection	NULL
Murine	NULL
B	NULL
cell	NULL
lines	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
described	NULL
by	NULL
Grossched	NULL
!	NULL

l	NULL
and	NULL
Baltimore	NULL
(	NULL
8	NULL
)	NULL
with	NULL
some	NULL
modifications	NULL
as	NULL
described	NULL
by	NULL
Nelms	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
.	NULL

For	NULL
pre-B	NULL
cell	NULL
transfections	NULL
12.5	NULL
ug/ml	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
were	NULL
added	NULL
to	NULL
half	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
at	NULL
37°C	NULL
with	NULL
7	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
with	NULL
60	NULL
ul	NULL
of	NULL
1	NULL
%	NULL
Cell	NULL
Culture	NULL
Lysis	NULL
Reagent	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
protein	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Luciferase	NULL
assay	NULL
100	NULL
ul	NULL
Luciferase	NULL
Assay	NULL
Reagent	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
added	NULL
to	NULL
20	NULL
pl	NULL
of	NULL
the	NULL
protein	NULL
extract	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
counted	NULL
for	NULL
15	NULL
s	NULL
in	NULL
a	NULL
Lumat	NULL
9501	NULL
luminometer	NULL
(	NULL
EG	NULL
&	NULL
G	NULL
Berthold	NULL
)	NULL
for	NULL
each	NULL
transfection	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
luminescence	NULL
from	NULL
RSV	NULL
@	NULL
gal	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
the	NULL
activity	NULL
levels	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

B-Galactosidase	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Galacto-light	NULL
kit	NULL
from	NULL
Tropix	NULL
(	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

5	NULL
pul	NULL
of	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
200	NULL
ul	NULL
of	NULL
AMPGD	NULL
reagent	NULL
for	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

100	NULL
41	NULL
of	NULL
Emerald	NULL
Accelerator	NULL
reagent	NULL
were	NULL
then	NULL
injected	NULL
and	NULL
the	NULL
activity	NULL
was	NULL
counted	NULL
in	NULL
the	NULL
Lumat	NULL
9501	NULL
luminometer	NULL
for	NULL
15	NULL
s.	NULL
In	NULL
order	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
levels	NULL
were	NULL
divided	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
B-gal	NULL
luminescence	NULL
and	NULL
corrected	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
protein	NULL
concentration	NULL
in	NULL
each	NULL
extract	NULL
.	NULL

The	NULL
results	NULL
are	NULL
represented	NULL
as	NULL
relative	NULL
activities	NULL
.	NULL

In	NULL
pre-B	NULL
cell	NULL
experiments	NULL
the	NULL
relative	NULL
activity	NULL
from	NULL
the	NULL
LPS-induced	NULL
cells	NULL
was	NULL
divided	NULL
by	NULL
the	NULL
level	NULL
of	NULL
activity	NULL
from	NULL
the	NULL
uninduced	NULL
cells	NULL
transfected	NULL
by	NULL
the	NULL
same	NULL
plasmid	NULL
and	NULL
is	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
.	NULL

Relative	NULL
luciferase	NULL
activities	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
done	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
,	NULL
were	NULL
determined	NULL
using	NULL
two	NULL
plasmid	NULL
preparations	NULL
of	NULL
two	NULL
different	NULL
isolates	NULL
of	NULL
each	NULL
plasmid	NULL
construct	NULL
.	NULL

RESULTS	NULL
An	NULL
inducible	NULL
factor	NULL
binds	NULL
360	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
mouse	NULL
kappa	NULL
intron	NULL
enhancer	NULL
within	NULL
the	NULL
kappa	NULL
MAR	NULL
In	NULL
the	NULL
last	NULL
few	NULL
years	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
originally	NULL
defined	NULL
kappa	NULL
intron	NULL
enhancer	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
includes	NULL
the	NULL
matrix-associated	NULL
region	NULL
(	NULL
MAR	NULL
)	NULL
(	NULL
3-5	NULL
)	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
site	NULL
of	NULL
nuclear	NULL
matrix	NULL
protein	NULL
interaction	NULL
,	NULL
although	NULL
no	NULL
specific	NULL
protein	NULL
interactions	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
there	NULL
were	NULL
any	NULL
regions	NULL
of	NULL
DNA-protein	NULL
interaction	NULL
that	NULL
had	NULL
not	NULL
yet	NULL
been	NULL
described	NULL
,	NULL
a	NULL
DNA-protein	NULL
binding	NULL
study	NULL
was	NULL
undertaken	NULL
upstream	NULL
of	NULL
the	NULL
mouse	NULL
intron	NULL
enhancer	NULL
,	NULL
within	NULL
the	NULL
MAR	NULL
.	NULL

By	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
an	NULL
inducible	NULL
binding	NULL
activity	NULL
within	NULL
the	NULL
MAR	NULL
was	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

A	NULL
series	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
both	NULL
B	NULL
and	NULL
non-B	NULL
cell	NULL
lines	NULL
revealed	NULL
a	NULL
number	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
with	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
a	NULL
33	NULL
bp	NULL
region	NULL
360	NULL
bases	NULL
upstream	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
pre-B	NULL
cell	NULL
lines	NULL
,	NULL
3-1	NULL
and	NULL
702/3	NULL
,	NULL
stimulated	NULL
with	NULL
bacterial	NULL
LPS	NULL
,	NULL
showed	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
DNA-protein	NULL
binding	NULL
activity	NULL
(	NULL
band	NULL
B4	NULL
,	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
although	NULL
extracts	NULL
from	NULL
all	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
including	NULL
pre-B	NULL
,	NULL
mature	NULL
B	NULL
,	NULL
plasma	NULL
cell	NULL
,	NULL
T	NULL
lymphoma	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
,	NULL
showed	NULL
some	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
described	NULL
below	NULL
,	NULL
we	NULL
subsequently	NULL
identified	NULL
this	NULL
as	NULL
a	NULL
site	NULL
homologous	NULL
to	NULL
an	NULL
API	NULL
motif	NULL
and	NULL
designate	NULL
it	NULL
xAP1	NULL
.	NULL

One	NULL
complex	NULL
formed	NULL
is	NULL
common	NULL
to	NULL
all	NULL
extracts	NULL
tested	NULL
(	NULL
B2	NULL
)	NULL
.	NULL

One	NULL
prominent	NULL
complex	NULL
formed	NULL
with	NULL
HeLa	NULL
cell	NULL
extracts	NULL
only	NULL
(	NULL
B3	NULL
)	NULL
.	NULL

The	NULL
T	NULL
cell	NULL
extract	NULL
,	NULL
EL4	NULL
,	NULL
also	NULL
results	NULL
in	NULL
a	NULL
unique	NULL
lower	NULL
complex	NULL
(	NULL
B5	NULL
)	NULL
which	NULL
consistently	NULL
runs	NULL
at	NULL
a	NULL
different	NULL
mobility	NULL
than	NULL
the	NULL
inducible	NULL
,	NULL
B	NULL
cell-specific	NULL
complex	NULL
(	NULL
B4	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
interactions	NULL
,	NULL
competitive	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Excess	NULL
non-radioactively	NULL
labeled	NULL
double-stranded	NULL
xApl	NULL
oligonucleotides	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
assay	NULL
mixtures	NULL
.	NULL

A	NULL
50-fold	NULL
excess	NULL
of	NULL
non-labeled	NULL
oligonucleotide	NULL
can	NULL
effectively	NULL
compete	NULL
for	NULL
all	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
seen	NULL
with	NULL
the	NULL
LPS-induced	NULL
pre-B	NULL
cell	NULL
extract	NULL
702/3	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
same	NULL
excess	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-xB	NULL
binding	NULL
motif	NULL
does	NULL
not	NULL
compete	NULL
for	NULL
any	NULL
of	NULL
the	NULL
W	NULL
A	NULL
o	NULL
40	NULL
53	NULL
+R	NULL
°_	NULL
as.~-c8§8639	NULL
T	NULL
I	NULL
6	NULL
6	NULL
RCR	NULL
3	NULL
S	NULL
U	NULL
WJ	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
702/83	NULL
1	NULL
70Z/3+	NULL
LPS	NULL
NC	NULL
NC	NULL
k-AP1	NULL
NS	NULL
L1	NULL
&	NULL
&	NULL
1	NULL
2	NULL
3	NULL
45	NULL
Figure	NULL
1	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
xAP1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Mobility	NULL
shift	NULL
analysis	NULL
of	NULL
the	NULL
xAP1	NULL
probe	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
line	NULL
HeLa	NULL
and	NULL
the	NULL
T	NULL
lymphoma	NULL
line	NULL
EL4	NULL
were	NULL
examined	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pre-B	NULL
cell	NULL
lines	NULL
3-1	NULL
and	NULL
702/3	NULL
,	NULL
the	NULL
B	NULL
lymphoma	NULL
line	NULL
WEHI	NULL
279	NULL
,	NULL
and	NULL
the	NULL
plasma	NULL
cell	NULL
lines	NULL
$	NULL
194	NULL
and	NULL
MPC11	NULL
.	NULL

The	NULL
pre-B	NULL
cell	NULL
lines	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
induced	NULL
with	NULL
15	NULL
ug/ml	NULL
LPS	NULL
for	NULL
24	NULL
h	NULL
before	NULL
nuclear	NULL
extract	NULL
preparations	NULL
.	NULL

Five	NULL
different	NULL
bound	NULL
complexes	NULL
were	NULL
identified	NULL
,	NULL
labeled	NULL
B1	NULL
-BS5	NULL
.	NULL

(	NULL
B	NULL
)	NULL
xAPI1	NULL
binding	NULL
inducibility	NULL
and	NULL
specificity	NULL
.	NULL

702/3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
15	NULL
ug/ml	NULL
LPS	NULL
for	NULL
24	NULL
h.	NULL
Extracts	NULL
from	NULL
induced	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
xAP1	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
50-fold	NULL
excess	NULL
unlabeled	NULL
xAP1	NULL
or	NULL
non-specific	NULL
(	NULL
NS	NULL
)	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
bold	NULL
arrow	NULL
indicates	NULL
the	NULL
LPS-inducible	NULL
(	NULL
B4	NULL
)	NULL
complex	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Resgarch	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
5427	NULL
complexes	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
all	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
70Z/3	NULL
extract	NULL
are	NULL
specific	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
xAPI1	NULL
33	NULL
bp	NULL
oligonucleotide	NULL
.	NULL

Similar	NULL
competition	NULL
assays	NULL
analyzing	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
formed	NULL
with	NULL
the	NULL
other	NULL
cell	NULL
extracts	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
complexes	NULL
formed	NULL
at	NULL
all	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
in	NULL
non-B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
focused	NULL
our	NULL
attention	NULL
on	NULL
the	NULL
B	NULL
cell-specific	NULL
and	NULL
major	NULL
inducible	NULL
protein-DNA	NULL
interaction	NULL
(	NULL
complex	NULL
B4	NULL
,	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
binding	NULL
activity	NULL
is	NULL
affected	NULL
by	NULL
other	NULL
inducers	NULL
of	NULL
kappa	NULL
expression	NULL
,	NULL
702/3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
for	NULL
8	NULL
h	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
for	NULL
4	NULL
or	NULL
8	NULL
h	NULL
or	NULL
IL-1	NULL
for	NULL
24	NULL
h.	NULL
As	NULL
seen	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
both	NULL
LPS	NULL
and	NULL
IL-1	NULL
induce	NULL
the	NULL
B4	NULL
protein	NULL
binding	NULL
activity	NULL
.	NULL

PMA	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
LPS-inducible	NULL
binding	NULL
activity	NULL
in	NULL
pre-B	NULL
cells	NULL
.	NULL

Figure	NULL
2	NULL
also	NULL
demonstrates	NULL
the	NULL
results	NULL
of	NULL
binding	NULL
assays	NULL
performed	NULL
with	NULL
7027/3	NULL
pre-B	NULL
cell	NULL
extracts	NULL
induced	NULL
with	NULL
100	NULL
U/ml	NULL
IL-4	NULL
and	NULL
50	NULL
or	NULL
100	NULL
U/ml	NULL
interferon-y	NULL
(	NULL
INF-y	NULL
)	NULL
.	NULL

Neither	NULL
IL-4	NULL
nor	NULL
INF-y	NULL
induce	NULL
protein	NULL
binding	NULL
by	NULL
the	NULL
33	NULL
bp	NULL
kappa	NULL
oligonucleotide	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
specific	NULL
DNA-protein	NULL
binding	NULL
interaction	NULL
present	NULL
in	NULL
all	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
,	NULL
but	NULL
which	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
pre-B	NULL
cells	NULL
by	NULL
both	NULL
LPS	NULL
and	NULL
IL-1	NULL
.	NULL

&	NULL
o	NULL
N	NULL
(	NULL
«	NULL
]	NULL
m	NULL
A	NULL
U	NULL
mad	NULL
az	NULL
w	NULL
ks	NULL
e	NULL
8	NULL
else	NULL
Ge	NULL
o	NULL
r	NULL
+	NULL
**	NULL
__	NULL
<	NULL
€	NULL
o	NULL
o	NULL
3	NULL
$	NULL
$	NULL
g	NULL
3	NULL
3	NULL
o	NULL
--	NULL
a	NULL
8	NULL
mn	NULL
A	NULL
1	NULL
Z	NULL
F	NULL
E	NULL
-o	NULL
c	NULL
0	NULL
L4	NULL
l	NULL
s	NULL
&	NULL
&	NULL
K	NULL
a	NULL
a	NULL
%	NULL
Figure	NULL
2	NULL
.	NULL

Induction	NULL
of	NULL
xAP1	NULL
binding	NULL
.	NULL

The	NULL
702/3	NULL
pre-B	NULL
cell	NULL
line	NULL
was	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
100	NULL
U/ml	NULL
IL-1	NULL
for	NULL
24	NULL
h	NULL
,	NULL
15	NULL
ug/ml	NULL
or	NULL
10	NULL
ug/ml	NULL
LPS	NULL
,	NULL
100	NULL
U/ml	NULL
IL-4	NULL
,	NULL
50	NULL
or	NULL
100	NULL
U/ml	NULL
of	NULL
interferon-y	NULL
(	NULL
INF-y	NULL
)	NULL
or	NULL
100	NULL
ng/ml	NULL
PMA	NULL
.	NULL

The	NULL
plasma	NULL
cell	NULL
line	NULL
$	NULL
194	NULL
was	NULL
also	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
10	NULL
pg/ml	NULL
LPS	NULL
.	NULL

The	NULL
inducible	NULL
,	NULL
B	NULL
cell-specific	NULL
(	NULL
B4	NULL
)	NULL
complex	NULL
is	NULL
marked	NULL
by	NULL
a	NULL
solid	NULL
arrow	NULL
.	NULL

5428	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
To	NULL
more	NULL
specifically	NULL
define	NULL
the	NULL
DNA-protein	NULL
contact	NULL
sites	NULL
,	NULL
DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
induced	NULL
702/3	NULL
pre-B	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
a	NULL
95	NULL
bp	NULL
Mboll-Alul	NULL
restriction	NULL
fragment	NULL
encompassing	NULL
the	NULL
oligonucleotide	NULL
sequence	NULL
.	NULL

Footprinting	NULL
of	NULL
the	NULL
B4	NULL
complex	NULL
resulted	NULL
in	NULL
detectable	NULL
protection	NULL
on	NULL
both	NULL
the	NULL
coding	NULL
and	NULL
non-coding	NULL
strands	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
along	NULL
with	NULL
a	NULL
number	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
both	NULL
within	NULL
and	NULL
flanking	NULL
the	NULL
protected	NULL
region	NULL
.	NULL

The	NULL
protected	NULL
region	NULL
contains	NULL
sequences	NULL
homologous	NULL
to	NULL
a	NULL
site	NULL
previously	NULL
described	NULL
as	NULL
a	NULL
nuclear	NULL
factor	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
identified	NULL
region	NULL
is	NULL
a	NULL
7	NULL
of	NULL
8	NULL
base	NULL
match	NULL
to	NULL
a	NULL
consensus	NULL
API	NULL
site	NULL
,	NULL
known	NULL
to	NULL
bind	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
kappa	NULL
intron	NULL
in	NULL
both	NULL
mouse	NULL
and	NULL
human	NULL
contains	NULL
an	NULL
API	NULL
site	NULL
that	NULL
binds	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
If	NULL
the	NULL
xAPI1	NULL
site	NULL
contributes	NULL
to	NULL
regulation	NULL
of	NULL
mouse	NULL
kappa	NULL
expression	NULL
,	NULL
it	NULL
might	NULL
be	NULL
expected	NULL
to	NULL
be	NULL
a	NULL
conserved	NULL
motif	NULL
within	NULL
the	NULL
human	NULL
kappa	NULL
intron	NULL
.	NULL

Indeed	NULL
,	NULL
an	NULL
AP1	NULL
consensus	NULL
motif	NULL
,	NULL
TG-ACTCA	NULL
,	NULL
was	NULL
identified	NULL
in	NULL
the	NULL
human	NULL
intron	NULL
almost	NULL
equidistant	NULL
from	NULL
the	NULL
NF-xB	NULL
binding	NULL
site	NULL
,	NULL
however	NULL
,	NULL
it	NULL
is	NULL
located	NULL
320	NULL
bp	NULL
3	NULL
'	NULL
rather	NULL
than	NULL
5	NULL
'	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
protein	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
xAP1	NULL
probe	NULL
bound	NULL
the	NULL
same	NULL
factors	NULL
as	NULL
the	NULL
consensus	NULL
API	NULL
(	NULL
cAP1	NULL
)	NULL
motif	NULL
(	NULL
10	NULL
)	NULL
and	NULL
the	NULL
human	NULL
©	NULL
HZ	NULL
fat	NULL
1	NULL
a08	NULL
-_	NULL
,	NULL
ape	NULL
T	NULL
3g	NULL
“	NULL
,	NULL
A	NULL
#	NULL
A	NULL
f	NULL
A	NULL
€	NULL
r	NULL
E2	NULL
.	NULL

~	NULL
:	NULL
w	NULL
?	NULL

|	NULL
A	NULL
«	NULL
»	NULL
»	NULL
#	NULL
\	NULL
A	NULL
E	NULL
R	NULL
«	NULL
**	NULL
}	NULL
+5	NULL
A	NULL
§	NULL
_	NULL
is	NULL
a	NULL
»	NULL
a	NULL
®	NULL
Sec	NULL
,	NULL
3571	NULL
3620	NULL
I	NULL
cecceess	NULL
cee	NULL
scee	NULL
I	NULL
CATGCAAAAA	NULL
TATGACTAAT	NULL
AATAATTTAG	NULL
CACAAAAATA	NULL
TTTCCCAATA	NULL
GTACGTTTTT	NULL
ATACTGATTA	NULL
TTATTIAAATC	NULL
GTGTTTTTAT	NULL
AAAGGGTTAT	NULL
cee	NULL
0000	NULL
os	NULL
o	NULL
TGACTAA	NULL
TGACTCA	NULL
Kappa	NULL
Consensus	NULL
AP1	NULL
Figure	NULL
3	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
of	NULL
the	NULL
B4	NULL
complex	NULL
and	NULL
identification	NULL
of	NULL
API	NULL
homology	NULL
.	NULL

A	NULL
95	NULL
bp	NULL
Mboll	NULL
-Alul	NULL
restriction	NULL
fragment	NULL
of	NULL
the	NULL
kappa	NULL
J-C	NULL
intron	NULL
,	NULL
encompassing	NULL
the	NULL
xAP1	NULL
oligonucleotide	NULL
sequence	NULL
,	NULL
was	NULL
used	NULL
in	NULL
a	NULL
preparative	NULL
binding	NULL
reaction	NULL
with	NULL
LPS-induced	NULL
702/3	NULL
pre-B	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

After	NULL
DNase	NULL
I	NULL
treatment	NULL
and	NULL
electrophoresis	NULL
,	NULL
the	NULL
B4	NULL
complex	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
denatured	NULL
before	NULL
loading	NULL
on	NULL
a	NULL
sequencing	NULL
gel	NULL
.	NULL

The	NULL
region	NULL
of	NULL
protection	NULL
is	NULL
indicated	NULL
.	NULL

Sequence	NULL
numbering	NULL
is	NULL
as	NULL
in	NULL
reference	NULL
26	NULL
.	NULL

The	NULL
homology	NULL
to	NULL
the	NULL
consensus	NULL
API	NULL
site	NULL
is	NULL
depicted	NULL
.	NULL

xAPIl	NULL
(	NULL
hLAP1	NULL
)	NULL
,	NULL
these	NULL
sites	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
xAP1	NULL
,	NULL
cAP1	NULL
and	NULL
hAPI1	NULL
sequences	NULL
all	NULL
effectively	NULL
competed	NULL
for	NULL
complex	NULL
B4	NULL
binding	NULL
by	NULL
the	NULL
radiolabeled	NULL
xAP1	NULL
sequence	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
non-specific	NULL
competitor	NULL
sequence	NULL
and	NULL
a	NULL
five	NULL
base	NULL
mutation	NULL
of	NULL
the	NULL
xAPI1	NULL
sequence	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
.	NULL

When	NULL
the	NULL
cAP1	NULL
or	NULL
hAP1probes	NULL
were	NULL
radiolabeled	NULL
and	NULL
used	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
identical	NULL
complexes	NULL
to	NULL
those	NULL
formed	NULL
with	NULL
the	NULL
mouse	NULL
xAP1	NULL
probe	NULL
were	NULL
observed	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
similarity	NULL
among	NULL
the	NULL
probes	NULL
is	NULL
confined	NULL
to	NULL
the	NULL
AP1	NULL
motif	NULL
and	NULL
demonstrates	NULL
that	NULL
flanking	NULL
sequences	NULL
do	NULL
not	NULL
contribute	NULL
to	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
protein-DNA	NULL
interaction	NULL
.	NULL

No	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
radiolabeled	NULL
mutant	NULL
xAP1	NULL
probe	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
serve	NULL
to	NULL
define	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
sequence	NULL
recognition	NULL
and	NULL
strongly	NULL
suggest	NULL
it	NULL
is	NULL
an	NULL
API	NULL
motif	NULL
.	NULL

API	NULL
sites	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
bound	NULL
by	NULL
protein	NULL
dimers	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
families	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Jun	NULL
forms	NULL
homodimers	NULL
and	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
can	NULL
heterodimerize	NULL
and	NULL
bind	NULL
to	NULL
API	NULL
sites	NULL
(	NULL
reviewed	NULL
in	NULL
11	NULL
)	NULL
.	NULL

The	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
bind	NULL
AP1-containing	NULL
regulatory	NULL
regions	NULL
and	NULL
can	NULL
activate	NULL
transcription	NULL
(	NULL
12	NULL
)	NULL
,	NULL
or	NULL
in	NULL
some	NULL
cases	NULL
down-regulate	NULL
transcription	NULL
(	NULL
13,14	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Fos	NULL
and	NULL
Jun	NULL
interact	NULL
Figure	NULL
4	NULL
.	NULL

Competition	NULL
analysis	NULL
of	NULL
xAPI1	NULL
binding	NULL
activity	NULL
.	NULL

Radiolabeled	NULL
xAPI	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
LPS-induced	NULL
702/3	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
NC	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
xAP1	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
4	NULL
bp	NULL
mutation	NULL
of	NULL
the	NULL
xAP1	NULL
sequence	NULL
(	NULL
mut	NULL
xAP1	NULL
)	NULL
,	NULL
the	NULL
human	NULL
xAP1	NULL
motif	NULL
(	NULL
AAP1	NULL
)	NULL
,	NULL
a	NULL
consensus	NULL
AP1	NULL
motif	NULL
(	NULL
cAP1	NULL
)	NULL
,	NULL
or	NULL
a	NULL
non-specific	NULL
competitor	NULL
(	NULL
NS	NULL
)	NULL
.	NULL

See	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
sequence	NULL
details	NULL
of	NULL
probes	NULL
used	NULL
.	NULL

Arrow	NULL
designates	NULL
the	NULL
B	NULL
cell-specific	NULL
(	NULL
B4	NULL
)	NULL
complex	NULL
.	NULL

A	NULL
o	NULL
-	NULL
-	NULL
40°	NULL
g	NULL
L	NULL
§	NULL
8	NULL
``	NULL
@	NULL
i	NULL
it	NULL
§	NULL
r	NULL
f	NULL
;	NULL
f	NULL
R	NULL
f	NULL
ejn	NULL
CCBC	NULL
|	NULL
RC|	NULL
|	NULL
HTH	NULL
T	NULL
as	NULL
ake	NULL
CO2	NULL
H4	NULL
+*EE	NULL
wes	NULL
[	NULL
|T	NULL
RTH	NULL
H	NULL
¥	NULL
||	NULL
I+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
1213	NULL
14151817	NULL
1819	NULL
20	NULL
21	NULL
B	NULL
702/3	NULL
cells	NULL
c-Jun	NULL
-+	NULL
c-fos	NULL
-+	NULL
NF-kB	NULL
Figure	NULL
5.	NULL
xAPI	NULL
supershifts	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
antibodies	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Antibodies	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
were	NULL
preincubated	NULL
in	NULL
binding	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
xAP1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Two	NULL
non-B	NULL
cell	NULL
line	NULL
extracts	NULL
,	NULL
HeLa	NULL
(	NULL
a	NULL
cervical	NULL
carcinoma	NULL
line	NULL
)	NULL
and	NULL
EL4	NULL
(	NULL
a	NULL
T	NULL
lymphoma	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
two	NULL
LPS-induced	NULL
pre-B	NULL
cell	NULL
line	NULL
extracts	NULL
,	NULL
3-1	NULL
and	NULL
702/3	NULL
,	NULL
and	NULL
the	NULL
mature	NULL
B	NULL
cell	NULL
extract	NULL
WEHI	NULL
279	NULL
were	NULL
preincubated	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
a	NULL
polyclonal	NULL
c-Jun	NULL
antibody	NULL
(	NULL
AB-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
,	NULL
a	NULL
polyclonal	NULL
c-Fos	NULL
antibody	NULL
(	NULL
AB-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
or	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
p65	NULL
component	NULL
of	NULL
NF-xB	NULL
(	NULL
Pharmingen	NULL
)	NULL
.	NULL

Presence	NULL
of	NULL
antibody	NULL
is	NULL
indicated	NULL
by	NULL
+	NULL
above	NULL
the	NULL
corresponding	NULL
lane	NULL
.	NULL

Supershifted	NULL
complexes	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
second	NULL
supershift	NULL
analysis	NULL
of	NULL
LPS-induced	NULL
70Z	NULL
nuclear	NULL
extracts	NULL
.	NULL

Antibodies	NULL
to	NULL
c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
p65	NULL
component	NULL
of	NULL
NF-xB	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
5429	NULL
with	NULL
the	NULL
xAPI1	NULL
site	NULL
,	NULL
antibodies	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
were	NULL
preincubated	NULL
in	NULL
binding	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
a	NULL
number	NULL
of	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Two	NULL
non-B	NULL
cell	NULL
line	NULL
extracts	NULL
,	NULL
HeLa	NULL
(	NULL
a	NULL
cervical	NULL
carcinoma	NULL
line	NULL
)	NULL
and	NULL
EL4	NULL
(	NULL
a	NULL
T	NULL
lymphoma	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
known	NULL
to	NULL
express	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
15	NULL
)	NULL
,	NULL
were	NULL
tested	NULL
along	NULL
with	NULL
three	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

Two	NULL
LPS-induced	NULL
pre-B	NULL
cell	NULL
line	NULL
extracts	NULL
,	NULL
3-1	NULL
and	NULL
702/3	NULL
,	NULL
the	NULL
mature	NULL
B	NULL
A	NULL
Intron	NULL
Enhancer	NULL
Jr	NULL
MAR	NULL
Cx	NULL
KpLUC	NULL
595	NULL
(	NULL
¥x	NULL
.	NULL

TATGACTAATAAT	NULL
promoterLUCIFERASE	NULL
sone	NULL
a	NULL
l	NULL
TACTGTTAACAAT	NULL
KpLUC	NULL
m595	NULL
Pre	NULL
B	NULL
Cell	NULL
Line	NULL
3-1	NULL
J	NULL
Unind	NULL
{	NULL
urs	NULL
B	NULL
PMA	NULL
N	NULL
LPS	NULL
&	NULL
PMA	NULL
Relative	NULL
.	NULL

Activity	NULL
Myeloma	NULL
Cell	NULL
Line	NULL
$	NULL
194	NULL
KpLUC	NULL
ms95s	NULL
KpLUC	NULL
595	NULL
M	NULL
si9	NULL
«	NULL
wn	NULL
o	NULL
in	NULL
o	NULL
in	NULL
LJ	NULL
w	NULL
m	NULL
o	NULL
bJ	NULL
Percent	NULL
-	NULL
Activity	NULL
Figure	NULL
6.	NULL
xAPI1	NULL
reporter	NULL
gene	NULL
constructs	NULL
and	NULL
transfection	NULL
results	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Plasmid	NULL
constructs	NULL
used	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
.	NULL

KpLUC	NULL
595	NULL
and	NULL
KpLUC	NULL
m595	NULL
contain	NULL
a	NULL
595	NULL
bp	NULL
intron	NULL
enhancer	NULL
fragment	NULL
with	NULL
the	NULL
endpoints	NULL
indicated	NULL
.	NULL

The	NULL
m595	NULL
enhancer	NULL
contains	NULL
5	NULL
base	NULL
substitutions	NULL
within	NULL
the	NULL
region	NULL
of	NULL
sequence	NULL
indicated	NULL
.	NULL

The	NULL
sites	NULL
of	NULL
base	NULL
changes	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
enhancer	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
KpLUC	NULL
reporter	NULL
gene	NULL
vector	NULL
which	NULL
contains	NULL
the	NULL
Vx21E	NULL
promoter	NULL
and	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Numbering	NULL
is	NULL
as	NULL
in	NULL
reference	NULL
16	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
expression	NULL
assays	NULL
in	NULL
3-1	NULL
pre-B	NULL
cells	NULL
uninduced	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
or	NULL
induced	NULL
with	NULL
LPS	NULL
(	NULL
lightly	NULL
stippled	NULL
bars	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
medium	NULL
stippled	NULL
bars	NULL
)	NULL
or	NULL
both	NULL
LPS	NULL
and	NULL
PMA	NULL
(	NULL
darkly	NULL
stippled	NULL
bars	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transient	NULL
transfection	NULL
results	NULL
of	NULL
the	NULL
myeloma	NULL
cell	NULL
line	NULL
$	NULL
194	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
mutated	NULL
enhancer	NULL
is	NULL
given	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
enhancer	NULL
construct	NULL
.	NULL

Values	NULL
are	NULL
averages	NULL
of	NULL
2-4	NULL
independent	NULL
experiments	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Normalized	NULL
LUC	NULL
activity	NULL
is	NULL
the	NULL
units	NULL
of	NULL
luciferase	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
units	NULL
of	NULL
3-galactosidase	NULL
activity	NULL
resulting	NULL
from	NULL
the	NULL
co-transfection	NULL
of	NULL
the	NULL
RSV	NULL
3-gal	NULL
plasmid	NULL
.	NULL

Errors	NULL
are	NULL
represented	NULL
as	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
differences	NULL
between	NULL
wild-type	NULL
activity	NULL
and	NULL
mutant	NULL
were	NULL
significant	NULL
to	NULL
P	NULL
<	NULL
0.05	NULL
.	NULL

5430	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
cell	NULL
extract	NULL
WEHI	NULL
279	NULL
,	NULL
and	NULL
the	NULL
two	NULL
non-B	NULL
cell	NULL
line	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
a	NULL
polyclonal	NULL
c-Jun	NULL
antibody	NULL
(	NULL
AB-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
,	NULL
a	NULL
polyclonal	NULL
c-Fos	NULL
antibody	NULL
(	NULL
AB-2	NULL
,	NULL
Oncogene	NULL
Science	NULL
)	NULL
or	NULL
a	NULL
control	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
p65	NULL
component	NULL
of	NULL
NF-xB	NULL
(	NULL
Pharmingen	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
analysis	NULL
in	NULL
Figure	NULL
5A	NULL
shows	NULL
a	NULL
strong	NULL
new	NULL
complex	NULL
of	NULL
larger	NULL
mobility	NULL
forms	NULL
when	NULL
the	NULL
c-Fos	NULL
antibody	NULL
is	NULL
added	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
16	NULL
and	NULL
20	NULL
)	NULL
,	NULL
and	NULL
two	NULL
faint	NULL
new	NULL
complexes	NULL
when	NULL
the	NULL
c-Jun	NULL
antibody	NULL
is	NULL
added	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
11	NULL
,	NULL
15	NULL
and	NULL
19	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
shifts	NULL
and	NULL
antibody	NULL
supershifts	NULL
were	NULL
repeated	NULL
in	NULL
a	NULL
second	NULL
,	NULL
independent	NULL
analysis	NULL
using	NULL
707	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
second	NULL
experiment	NULL
the	NULL
antibody	NULL
supershifts	NULL
are	NULL
readily	NULL
apparent	NULL
only	NULL
in	NULL
induced	NULL
extracts	NULL
when	NULL
either	NULL
c-Fos	NULL
or	NULL
c-Jun	NULL
,	NULL
but	NULL
not	NULL
when	NULL
the	NULL
non-specific	NULL
p65	NULL
,	NULL
antibodies	NULL
are	NULL
added	NULL
.	NULL

The	NULL
two	NULL
complexes	NULL
seen	NULL
in	NULL
the	NULL
anti-c-Jun	NULL
supershift	NULL
likely	NULL
reflect	NULL
Jun-Jun	NULL
and	NULL
Fos	NULL
dimers	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
the	NULL
inducible	NULL
B4	NULL
complex	NULL
decreases	NULL
in	NULL
intensity	NULL
and	NULL
smears	NULL
upward	NULL
whenever	NULL
a	NULL
specific	NULL
supershift	NULL
is	NULL
seen	NULL
.	NULL

It	NULL
is	NULL
difficult	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
minor	NULL
upper	NULL
complexes	NULL
also	NULL
decrease	NULL
in	NULL
intensity	NULL
due	NULL
to	NULL
the	NULL
smeared	NULL
supershift	NULL
of	NULL
the	NULL
lower	NULL
,	NULL
most	NULL
intense	NULL
complex	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
in	NULL
the	NULL
major	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
newly	NULL
identified	NULL
kappa	NULL
binding	NULL
site	NULL
in	NULL
B	NULL
and	NULL
non-B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
thereby	NULL
confirming	NULL
its	NULL
identity	NULL
as	NULL
an	NULL
API	NULL
site	NULL
.	NULL

The	NULL
site	NULL
alone	NULL
or	NULL
in	NULL
multimers	NULL
does	NULL
not	NULL
enhance	NULL
transcription	NULL
but	NULL
can	NULL
influence	NULL
kappa	NULL
expression	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
enhancer	NULL
The	NULL
murine	NULL
xAP1	NULL
motif	NULL
was	NULL
hypothesized	NULL
to	NULL
bind	NULL
factors	NULL
that	NULL
activate	NULL
transcription	NULL
in	NULL
induced	NULL
pre-B	NULL
cells	NULL
and	NULL
mature	NULL
cells	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
the	NULL
xB	NULL
site	NULL
,	NULL
which	NULL
has	NULL
a	NULL
similar	NULL
factor	NULL
binding	NULL
profile	NULL
.	NULL

The	NULL
xB	NULL
site	NULL
,	NULL
when	NULL
subcloned	NULL
in	NULL
multiple	NULL
copies	NULL
upstream	NULL
of	NULL
a	NULL
promoter-containing	NULL
reporter	NULL
gene	NULL
significantly	NULL
enhances	NULL
reporter	NULL
gene	NULL
transcription	NULL
(	NULL
16	NULL
)	NULL
.	NULL

A	NULL
more	NULL
recently	NULL
identified	NULL
inducible	NULL
binding	NULL
activity	NULL
at	NULL
the	NULL
xA	NULL
site	NULL
(	NULL
2	NULL
)	NULL
can	NULL
also	NULL
independently	NULL
enhance	NULL
transcription	NULL
when	NULL
the	NULL
xA	NULL
site	NULL
is	NULL
multimerized	NULL
(	NULL
Nelms	NULL
and	NULL
Van	NULL
Ness	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

An	NULL
experiment	NULL
was	NULL
therefore	NULL
designed	NULL
to	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
1-4	NULL
copies	NULL
of	NULL
the	NULL
xAP1	NULL
motif	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
in	NULL
pre-B	NULL
or	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
xAP1	NULL
motif	NULL
was	NULL
subcloned	NULL
in	NULL
1-4	NULL
copies	NULL
upstream	NULL
of	NULL
the	NULL
kappa	NULL
promoter	NULL
and	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
pre-B	NULL
cell	NULL
lines	NULL
3-1	NULL
and	NULL
1-8	NULL
which	NULL
were	NULL
induced	NULL
with	NULL
LPS	NULL
for	NULL
24	NULL
h.	NULL
No	NULL
significant	NULL
activity	NULL
was	NULL
seen	NULL
,	NULL
even	NULL
upon	NULL
induction	NULL
of	NULL
any	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
another	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
1-8	NULL
,	NULL
and	NULL
the	NULL
plasma	NULL
cell	NULL
line	NULL
$	NULL
194	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
xAPI1	NULL
site	NULL
is	NULL
unable	NULL
to	NULL
act	NULL
independently	NULL
to	NULL
regulate	NULL
kappa	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Previously	NULL
identified	NULL
DNA	NULL
protein	NULL
binding	NULL
motifs	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
binding	NULL
motifs	NULL
even	NULL
when	NULL
the	NULL
motif	NULL
alone	NULL
has	NULL
no	NULL
detectable	NULL
enhancer	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
xAPI1	NULL
site	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
factor	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
enhancer	NULL
,	NULL
a	NULL
595	NULL
bp	NULL
enhancer	NULL
construct	NULL
containing	NULL
five	NULL
base	NULL
changes	NULL
within	NULL
the	NULL
xAP1	NULL
motif	NULL
was	NULL
compared	NULL
for	NULL
activity	NULL
with	NULL
a	NULL
wild-type	NULL
xAP1-containing	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
base	NULL
substitutions	NULL
made	NULL
within	NULL
the	NULL
xAP1	NULL
motif	NULL
are	NULL
the	NULL
same	NULL
as	NULL
used	NULL
in	NULL
the	NULL
competitive	NULL
binding	NULL
assay	NULL
described	NULL
above	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
these	NULL
changes	NULL
has	NULL
no	NULL
protein	NULL
binding	NULL
activity	NULL
detectable	NULL
by	NULL
mobility	NULL
shift	NULL
assay	NULL
and	NULL
can	NULL
not	NULL
compete	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
a	NULL
wild-type	NULL
API	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
enhancer	NULL
construct	NULL
,	NULL
KpLUC	NULL
595	NULL
,	NULL
and	NULL
the	NULL
mutated	NULL
enhancer	NULL
construct	NULL
,	NULL
KpLUC	NULL
m595	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
,	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
3-1	NULL
pre-B	NULL
cells	NULL
in	NULL
duplicate	NULL
as	NULL
well	NULL
as	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
in	NULL
quadruplicate	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
co-transfection	NULL
with	NULL
a	NULL
RSV	NULL
$	NULL
-galactosidase	NULL
reporter	NULL
gene	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
endogenous	NULL
kappa	NULL
enhancer	NULL
activity	NULL
is	NULL
inducible	NULL
in	NULL
the	NULL
pre-B	NULL
cell	NULL
line	NULL
with	NULL
mitogens	NULL
and	NULL
is	NULL
constitutive	NULL
in	NULL
the	NULL
myeloma	NULL
cell	NULL
line	NULL
$	NULL
194	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
functional	NULL
analyses	NULL
of	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
xAPI	NULL
site	NULL
were	NULL
examined	NULL
for	NULL
effects	NULL
on	NULL
both	NULL
inducible	NULL
and	NULL
constitutive	NULL
enhancer	NULL
activity	NULL
.	NULL

Pre-B	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
KpLUC	NULL
595	NULL
and	NULL
KpLUC	NULL
m595	NULL
and	NULL
induced	NULL
with	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
both	NULL
for	NULL
20	NULL
h	NULL
before	NULL
cell	NULL
harvest	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
enhancer	NULL
activity	NULL
was	NULL
evident	NULL
in	NULL
extracts	NULL
derived	NULL
from	NULL
transfection	NULL
of	NULL
both	NULL
constructs	NULL
(	NULL
compared	NULL
to	NULL
KpLUC	NULL
control	NULL
)	NULL
,	NULL
however	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
AP1	NULL
site	NULL
resulted	NULL
in	NULL
an	NULL
~80	NULL
%	NULL
loss	NULL
of	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
neither	NULL
enhancer	NULL
construct	NULL
responded	NULL
to	NULL
the	NULL
PMA	NULL
induction	NULL
.	NULL

When	NULL
co-stimulated	NULL
with	NULL
both	NULL
LPS	NULL
and	NULL
PMA	NULL
a	NULL
loss	NULL
in	NULL
the	NULL
mutated	NULL
reporter	NULL
gene	NULL
induction	NULL
was	NULL
seen	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
LPS	NULL
alone	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
inducible	NULL
xAP1	NULL
site	NULL
binding	NULL
activity	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
was	NULL
the	NULL
same	NULL
as	NULL
the	NULL
pattern	NULL
of	NULL
transcriptional	NULL
activation	NULL
attributed	NULL
to	NULL
this	NULL
site	NULL
through	NULL
the	NULL
xAP1	NULL
mutation	NULL
analysis	NULL
.	NULL

The	NULL
binding	NULL
and	NULL
activating	NULL
potential	NULL
of	NULL
this	NULL
site	NULL
is	NULL
increased	NULL
by	NULL
LPS	NULL
induction	NULL
but	NULL
not	NULL
by	NULL
PMA	NULL
induction	NULL
.	NULL

The	NULL
transfection	NULL
of	NULL
these	NULL
constructs	NULL
into	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
also	NULL
demonstrated	NULL
a	NULL
loss	NULL
of	NULL
connstitutive	NULL
enhancer	NULL
activity	NULL
upon	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
xAPI1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

A	NULL
25	NULL
%	NULL
loss	NULL
in	NULL
activity	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
was	NULL
seen	NULL
when	NULL
comparing	NULL
the	NULL
mutated	NULL
enhancer	NULL
to	NULL
the	NULL
wild-type	NULL
enhancer	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
API	NULL
site	NULL
are	NULL
responsible	NULL
for	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
transcriptional	NULL
activating	NULL
capacity	NULL
of	NULL
the	NULL
kappa	NULL
intron	NULL
enhancer	NULL
both	NULL
early	NULL
and	NULL
late	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

However	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
inactivity	NULL
of	NULL
the	NULL
site	NULL
alone	NULL
or	NULL
in	NULL
multimers	NULL
,	NULL
this	NULL
activity	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
factor	NULL
binding	NULL
motifs	NULL
within	NULL
the	NULL
kappa	NULL
intron	NULL
.	NULL

DISCUSSION	NULL
A	NULL
number	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
kappa	NULL
intron	NULL
enhancer	NULL
over	NULL
the	NULL
last	NULL
few	NULL
years	NULL
(	NULL
reviewed	NULL
in	NULL
18	NULL
)	NULL
.	NULL

This	NULL
upstream	NULL
segment	NULL
includes	NULL
the	NULL
nuclear	NULL
matrix-associated	NULL
region	NULL
where	NULL
no	NULL
specific	NULL
factor	NULL
interactions	NULL
have	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
scanning	NULL
the	NULL
DNA	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
well-characterized	NULL
kappa	NULL
intron	NULL
enhancer	NULL
for	NULL
possible	NULL
protein	NULL
interactions	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
360	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
NF-xB	NULL
binding	NULL
site	NULL
(	NULL
mouse	NULL
)	NULL
or	NULL
320	NULL
bp	NULL
downstream	NULL
of	NULL
the	NULL
NF-xB	NULL
site	NULL
(	NULL
human	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
binding	NULL
activity	NULL
is	NULL
inducible	NULL
in	NULL
pre-B	NULL
cells	NULL
and	NULL
that	NULL
it	NULL
is	NULL
also	NULL
present	NULL
,	NULL
albeit	NULL
at	NULL
apparently	NULL
lower	NULL
levels	NULL
,	NULL
in	NULL
later	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
pre-B	NULL
cells	NULL
,	NULL
induced	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
IL-1	NULL
,	NULL
show	NULL
significantly	NULL
more	NULL
binding	NULL
activity	NULL
than	NULL
uninduced	NULL
extracts	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
revealed	NULL
a	NULL
region	NULL
of	NULL
protection	NULL
containing	NULL
a	NULL
sequence	NULL
motif	NULL
with	NULL
a	NULL
seven	NULL
of	NULL
eight	NULL
base	NULL
match	NULL
to	NULL
the	NULL
consensus	NULL
API	NULL
binding	NULL
site	NULL
.	NULL

IL-1	NULL
and	NULL
PMA	NULL
have	NULL
both	NULL
been	NULL
demonstrated	NULL
to	NULL
induce	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
expression	NULL
(	NULL
19,20	NULL
)	NULL
,	NULL
which	NULL
bind	NULL
as	NULL
heterodimers	NULL
to	NULL
consensus	NULL
AP1	NULL
motifs	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
xAPI	NULL
protein	NULL
binding	NULL
activity	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
was	NULL
not	NULL
seen	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
some	NULL
differences	NULL
exist	NULL
between	NULL
the	NULL
induction	NULL
of	NULL
factors	NULL
interacting	NULL
at	NULL
this	NULL
API	NULL
site	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
the	NULL
classic	NULL
PMA-inducible	NULL
heterodimeric	NULL
Fos/Jun	NULL
complex	NULL
previously	NULL
described	NULL
(	NULL
20,21	NULL
)	NULL
.	NULL

The	NULL
same	NULL
sequence	NULL
that	NULL
is	NULL
present	NULL
in	NULL
the	NULL
xAPI	NULL
motif	NULL
has	NULL
been	NULL
used	NULL
in	NULL
studies	NULL
examining	NULL
variant	NULL
API	NULL
motifs	NULL
of	NULL
other	NULL
genes	NULL
and	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
Fos	NULL
and	NULL
Jun	NULL
(	NULL
22,23	NULL
)	NULL
.	NULL

These	NULL
two	NULL
studies	NULL
confirm	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
sequence	NULL
identical	NULL
to	NULL
that	NULL
found	NULL
in	NULL
the	NULL
xAP1	NULL
motif	NULL
to	NULL
bind	NULL
Fos	NULL
and	NULL
Jun	NULL
or	NULL
to	NULL
compete	NULL
for	NULL
factor	NULL
binding	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
22,23	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
which	NULL
specifically	NULL
identify	NULL
a	NULL
variant	NULL
API	NULL
in	NULL
the	NULL
kappa	NULL
intron	NULL
,	NULL
are	NULL
consistent	NULL
with	NULL
these	NULL
studies	NULL
,	NULL
and	NULL
demonstrate	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
consensus	NULL
API	NULL
sequence	NULL
motif	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
protein	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
murine	NULL
xAP1	NULL
probe	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
a	NULL
mutated	NULL
API	NULL
motif	NULL
to	NULL
compete	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
this	NULL
motif	NULL
confirms	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
interaction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Antibodies	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
epitopes	NULL
were	NULL
capable	NULL
of	NULL
supershifting	NULL
the	NULL
protein	NULL
complex	NULL
bound	NULL
to	NULL
the	NULL
xAP1	NULL
site	NULL
.	NULL

This	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
in	NULL
the	NULL
DNA-bound	NULL
complexes	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
the	NULL
supershift	NULL
with	NULL
c-Fos	NULL
was	NULL
much	NULL
stronger	NULL
than	NULL
that	NULL
with	NULL
c-Jun	NULL
,	NULL
which	NULL
may	NULL
be	NULL
due	NULL
to	NULL
different	NULL
antibody	NULL
affinities	NULL
for	NULL
their	NULL
respective	NULL
epitopes	NULL
on	NULL
the	NULL
DNA-bound	NULL
proteins	NULL
.	NULL

Differences	NULL
were	NULL
also	NULL
seen	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
c-Jun	NULL
supershifts	NULL
which	NULL
are	NULL
more	NULL
apparent	NULL
in	NULL
HeLa	NULL
and	NULL
pre-B	NULL
cell	NULL
extracts	NULL
than	NULL
in	NULL
mature	NULL
T	NULL
or	NULL
B	NULL
extracts	NULL
.	NULL

The	NULL
differences	NULL
could	NULL
indicate	NULL
the	NULL
binding	NULL
of	NULL
Jun	NULL
family	NULL
members	NULL
that	NULL
do	NULL
not	NULL
cross-react	NULL
with	NULL
this	NULL
c-Jun	NULL
antibody	NULL
in	NULL
some	NULL
extracts	NULL
,	NULL
and	NULL
are	NULL
therefore	NULL
not	NULL
detected	NULL
in	NULL
this	NULL
analysis	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
are	NULL
specific	NULL
to	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
(	NULL
Oncogene	NULL
Science	NULL
)	NULL
and	NULL
are	NULL
not	NULL
known	NULL
to	NULL
significantly	NULL
cross-react	NULL
with	NULL
other	NULL
family	NULL
members	NULL
.	NULL

Therefore	NULL
,	NULL
other	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
proteins	NULL
may	NULL
be	NULL
present	NULL
in	NULL
the	NULL
bound	NULL
complexes	NULL
and	NULL
are	NULL
not	NULL
supershifted	NULL
by	NULL
the	NULL
antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
multiple	NULL
specific	NULL
xAP1-protein	NULL
complexes	NULL
also	NULL
supports	NULL
the	NULL
possibility	NULL
that	NULL
different	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
member	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
may	NULL
bind	NULL
the	NULL
xAPI1	NULL
site	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
number	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
are	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
are	NULL
inducible	NULL
by	NULL
mitogens	NULL
and	NULL
cytokines	NULL
(	NULL
21,24	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
to	NULL
examine	NULL
the	NULL
components	NULL
of	NULL
these	NULL
B	NULL
cell-specific	NULL
complexes	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
identify	NULL
all	NULL
of	NULL
the	NULL
proteins	NULL
involved	NULL
and	NULL
determine	NULL
whether	NULL
there	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
Fos	NULL
or	NULL
Jun	NULL
family	NULL
member	NULL
.	NULL

The	NULL
human	NULL
J-C	NULL
intron	NULL
also	NULL
contains	NULL
a	NULL
perfect	NULL
consensus	NULL
API	NULL
site	NULL
.	NULL

This	NULL
motif	NULL
binds	NULL
a	NULL
protein	NULL
complex	NULL
which	NULL
can	NULL
also	NULL
be	NULL
supershifted	NULL
by	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
can	NULL
compete	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
murine	NULL
API	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
human	NULL
API	NULL
site	NULL
,	NULL
however	NULL
,	NULL
is	NULL
located	NULL
320	NULL
bases	NULL
downstream	NULL
of	NULL
the	NULL
xB	NULL
site	NULL
,	NULL
in	NULL
the	NULL
3	NULL
'	NULL
region	NULL
flanking	NULL
the	NULL
enhancer	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
in	NULL
different	NULL
relative	NULL
positions	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
API	NULL
site	NULL
has	NULL
been	NULL
conserved	NULL
between	NULL
species	NULL
.	NULL

The	NULL
conservation	NULL
of	NULL
an	NULL
API	NULL
site	NULL
within	NULL
both	NULL
intron	NULL
enhancer	NULL
regions	NULL
supports	NULL
the	NULL
hypothesis	NULL
that	NULL
it	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
kappa	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
the	NULL
API	NULL
oligonucleotide	NULL
alone	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
kappa	NULL
promoter	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
number	NULL
of	NULL
other	NULL
factor	NULL
binding	NULL
motifs	NULL
which	NULL
demonstrate	NULL
enhancer	NULL
activity	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
motifs	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
distal	NULL
API	NULL
motif	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
transcription	NULL
when	NULL
placed	NULL
in	NULL
multiple	NULL
copies	NULL
upstream	NULL
of	NULL
a	NULL
promoter	NULL
and	NULL
reporter	NULL
gene	NULL
,	NULL
however	NULL
,	NULL
the	NULL
fragment	NULL
used	NULL
contained	NULL
other	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
site	NULL
's	NULL
inability	NULL
to	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
alone	NULL
,	NULL
the	NULL
API	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
enhancer	NULL
acts	NULL
to	NULL
increase	NULL
its	NULL
activity	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
the	NULL
API	NULL
motif	NULL
to	NULL
intron	NULL
enhancer	NULL
activation	NULL
was	NULL
demonstrated	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
enhancer	NULL
activity	NULL
upon	NULL
mutation	NULL
of	NULL
the	NULL
sequence	NULL
motif	NULL
.	NULL

The	NULL
loss	NULL
in	NULL
enhancer	NULL
activity	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
5431	NULL
was	NULL
greatest	NULL
in	NULL
LPS-induced	NULL
pre-B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
significant	NULL
loss	NULL
of	NULL
enhancer	NULL
induction	NULL
is	NULL
somewhat	NULL
surprising	NULL
given	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
known	NULL
activators	NULL
,	NULL
such	NULL
as	NULL
NF-xB	NULL
and	NULL
xB-FA	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
dramatic	NULL
loss	NULL
of	NULL
enhancer	NULL
activity	NULL
has	NULL
been	NULL
noted	NULL
upon	NULL
deletion	NULL
of	NULL
other	NULL
enhancer	NULL
motifs	NULL
.	NULL

Notably	NULL
,	NULL
mutation	NULL
of	NULL
xEl	NULL
and	NULL
xE2	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
80	NULL
and	NULL
90	NULL
%	NULL
enhancer	NULL
activity	NULL
,	NULL
respectively	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
NF-xB	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
expanding	NULL
array	NULL
of	NULL
enhancer	NULL
motifs	NULL
,	NULL
indivdual	NULL
binding	NULL
sites	NULL
can	NULL
significantly	NULL
influence	NULL
transcriptional	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
unlike	NULL
previous	NULL
transfection	NULL
constructs	NULL
that	NULL
used	NULL
smaller	NULL
(	NULL
200-300	NULL
bp	NULL
)	NULL
enhancer-containing	NULL
fragments	NULL
,	NULL
our	NULL
constructs	NULL
contain	NULL
additional	NULL
flanking	NULL
sequence	NULL
,	NULL
including	NULL
newly	NULL
described	NULL
silencer	NULL
regions	NULL
(	NULL
26	NULL
)	NULL
.	NULL

From	NULL
these	NULL
results	NULL
it	NULL
is	NULL
becoming	NULL
increasingly	NULL
evident	NULL
that	NULL
additional	NULL
portions	NULL
of	NULL
the	NULL
J-C	NULL
intron	NULL
impact	NULL
on	NULL
enhancer	NULL
function	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
bZIP	NULL
regions	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
are	NULL
capable	NULL
of	NULL
physically	NULL
interacting	NULL
with	NULL
NF-xB	NULL
p65	NULL
and	NULL
result	NULL
in	NULL
enhanced	NULL
binding	NULL
and	NULL
activation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

These	NULL
authors	NULL
suggest	NULL
a	NULL
combinatorial	NULL
mechanism	NULL
of	NULL
gene	NULL
regulation	NULL
involving	NULL
cross-coupling	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
both	NULL
motifs	NULL
and	NULL
the	NULL
interaction	NULL
of	NULL
transcription	NULL
factor	NULL
families	NULL
within	NULL
the	NULL
kappa	NULL
intron	NULL
may	NULL
therefore	NULL
ensure	NULL
the	NULL
highest	NULL
possible	NULL
level	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
also	NULL
noteworthy	NULL
that	NULL
this	NULL
newly	NULL
identified	NULL
AP1	NULL
motif	NULL
is	NULL
present	NULL
within	NULL
the	NULL
kappa	NULL
matrix-associated	NULL
region	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
intron	NULL
enhancer	NULL
.	NULL

API	NULL
binding	NULL
activity	NULL
has	NULL
recently	NULL
been	NULL
described	NULL
within	NULL
the	NULL
nuclear	NULL
matrix	NULL
fraction	NULL
of	NULL
HeLa	NULL
cell	NULL
extracts	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
xAP1	NULL
motif	NULL
may	NULL
therefore	NULL
play	NULL
a	NULL
role	NULL
in	NULL
both	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
kappa	NULL
gene	NULL
expression	NULL
and	NULL
in	NULL
the	NULL
association	NULL
of	NULL
the	NULL
locus	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
.	NULL

ACKNOWEDGEMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
GM37687	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Minnesota	NULL
Medical	NULL
Foundation	NULL
.	NULL

J.S	NULL
.	NULL

was	NULL
a	NULL
recipient	NULL
of	NULL
an	NULL
Immunology	NULL
Training	NULL
Grant	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072:63-80	NULL
.	NULL

2	NULL
.	NULL

Nelms	NULL
,	NULL
K.	NULL
,	NULL
Hromas	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Van	NULL
Ness	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:1037-1043	NULL
.	NULL

3	NULL
.	NULL

Cockerill	NULL
,	NULL
P.N	NULL
.	NULL

and	NULL
Garrard	NULL
,	NULL
W.T	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
44:273-282	NULL
.	NULL

4	NULL
.	NULL

Dickinson	NULL
,	NULL
L.A.	NULL
,	NULL
Joh	NULL
,	NULL
T.	NULL
,	NULL
Kohwi	NULL
,	NULL
¥Y	NULL
.	NULL

and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70:631-645	NULL
.	NULL

5	NULL
.	NULL

Van	NULL
Wijnen	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Bidwell	NULL
,	NULL
J.P.	NULL
,	NULL
Fey	NULL
,	NULL
E.G	NULL
.	NULL

,	NULL
Penman	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Lian	NULL
,	NULL
J.B.	NULL
,	NULL
Stein	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Stein	NULL
,	NULL
G.S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Biochemistry	NULL
32:8397-8402	NULL
.	NULL

6	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-89	NULL
.	NULL

7	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
Barthelmas	NULL
,	NULL
R.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
L.	NULL
,	NULL
Schenk	NULL
,	NULL
B.	NULL
,	NULL
Zarius	NULL
,	NULL
S.	NULL
,	NULL
Swoboda	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Mercurio	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8:465-473	NULL
.	NULL

8	NULL
.	NULL

GrosschedI	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
:	NULL
885-897	NULL
.	NULL

9	NULL
.	NULL

Bradford	NULL
,	NULL
M.M	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

10	NULL
.	NULL

Diamond	NULL
,	NULL
Miner	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Yoshinaga	NULL
,	NULL
S.K	NULL
.	NULL

and	NULL
Yamamoto	NULL
,	NULL
K.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
249:1266-1272	NULL
.	NULL

11	NULL
.	NULL

Radler-Pohl	NULL
,	NULL
A.	NULL
,	NULL
Gebel	NULL
,	NULL
S.	NULL
,	NULL
Sachsenmaier	NULL
,	NULL
C.	NULL
,	NULL
Konig	NULL
,	NULL
H.	NULL
,	NULL
Kramer	NULL
,	NULL
M.	NULL
,	NULL
Ochler	NULL
,	NULL
T.	NULL
,	NULL
Streile	NULL
,	NULL
M.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Cato	NULL
,	NULL
A.C.B	NULL
.	NULL

,	NULL
Angel	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Herlich	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

684:127-148	NULL
.	NULL

12	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
Luk	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Curran	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3624-3632	NULL
.	NULL

13	NULL
.	NULL

Li	NULL
,	NULL
L.	NULL
,	NULL
Chambard	NULL
,	NULL
J-C.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Olson	NULL
,	NULL
E.N	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6:676-689	NULL
.	NULL

14	NULL
.	NULL

McBride	NULL
,	NULL
K.	NULL
,	NULL
Robitaille	NULL
,	NULL
L.	NULL
,	NULL
Tremblay	NULL
,	NULL
S.	NULL
,	NULL
Argentin	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nemer	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:600-612	NULL
.	NULL

15	NULL
.	NULL

Jensen	NULL
,	NULL
D.E	NULL
.	NULL

,	NULL
Frankis	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
Sando	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6:1219-1225	NULL
.	NULL

5432	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1994	NULL
,	NULL
Vol	NULL
.	NULL

22	NULL
,	NULL
No	NULL
.	NULL

24	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Lenardo	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58:227-229	NULL
.	NULL

Annweiler	NULL
,	NULL
A	NULL
.	NULL

Muller	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Wirth	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
:	NULL
1503-1509	NULL
.	NULL

Staudt	NULL
,	NULL
L.M	NULL
.	NULL

and	NULL
Lenardo	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:373-398	NULL
.	NULL

Muegge.K	NULL
.	NULL

,	NULL
Williams	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Kant	NULL
,	NULL
J.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Schmidt	NULL
,	NULL
A.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

and	NULL
Durum	NULL
,	NULL
S.K	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
246:249-251.	NULL
.	NULL

Murphy	NULL
,	NULL
J.J	NULL
.	NULL

and	NULL
Norton	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Leukemia	NULL
Res	NULL
.	NULL

17:657-662.	NULL
.	NULL

Murphy	NULL
,	NULL
J.J.	NULL
,	NULL
Tracz	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Norton	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Immunology	NULL
69:490-493.	NULL
.	NULL

Ryseck	NULL
,	NULL
R.P	NULL
.	NULL

and	NULL
Bravo	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6:533-542.	NULL
.	NULL

Hadman	NULL
,	NULL
M.	NULL
,	NULL
Loo	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Bos	NULL
,	NULL
T.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8:1895-1903.	NULL
.	NULL

Tilzey	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Chiles	NULL
,	NULL
T.C	NULL
.	NULL

and	NULL
Rothstein	NULL
,	NULL
T.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

175:77-83.	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236:1573-1577.	NULL
.	NULL

Pierce	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Gifford	NULL
,	NULL
A.M.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1431-1437.	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Greene	NULL
,	NULL
W.C.	NULL
,	NULL
Angel	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Herrlich	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

93:3879-3891.	NULL
.	NULL

Max	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
Maizel	NULL
,	NULL
J.V	NULL
.	NULL

and	NULL
Leder	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256:5116-5120.	NULL
.	NULL

van	NULL
Wijnen	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Bidwell	NULL
,	NULL
J.P.	NULL
,	NULL
Fey	NULL
,	NULL
E.G	NULL
.	NULL

,	NULL
Penman	NULL
,	NULL
S.	NULL
,	NULL
Lian	NULL
,	NULL
J.B.	NULL
,	NULL
Stein	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
and	NULL
Stein	NULL
,	NULL
G.S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Biochemistry	NULL
32:8397-8402.	NULL
.	NULL

Fulton	NULL
,	NULL
R.	NULL
and	NULL
Van	NULL
Ness	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:4941-4947	NULL
.	NULL

